No Data
No Data
No Data
No Data
No Data
Pelinong announced the termination of the placement agreement
Peilinong itself (01498) announced that on April 12, 2024 (after the trading period), the placement agent delivered a written notice of termination to terminate the placement agreement in accordance with the terms of the placement agreement. Upon termination of the placement agreement, all of the obligations of each party to the placement agreement will be terminated and no party shall bring any claim against the other party in respect of any matter or event arising out of or relating to the placement agreement, except for any prior violator of any obligation under the placement agreement.
新浪港股Apr 14 20:17 ET
Pelinon's side (01498): Termination of placement agreement
Pelinong Corporation (01498) announced that on April 12, 2024 (after the trading period), the placement agent was delivered...
Zhitong FinanceApr 12 10:44 ET
PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9%
PuraPharm Corporation (HKG:1498) saw a decline in attributable loss for the year ended Dec. 31, 2023, to HK$106.1 million from HK$120.2 million during the year-ago period, a filing posted on the Hong
MT NewswiresApr 1 05:40 ET
Pelinong (01498) plans to sell a maximum of 50 million shares at a 6.02% discount to raise about HK$37.7 million
Peilinong (01498) issued an announcement. On March 28, 2024, the company and the placement agent signed an placement agreement...
Zhitong FinanceMar 28 13:45 ET
Peilinong Benfang (01498) announced 2023 results. Net loss of HK$106 million narrowed 11.76% year over year
Pelinong Benfang (01498) announced its 2023 results, with revenue of approximately HK$407 million, a year-on-year decrease of 9.2%...
Zhitong FinanceMar 28 13:01 ET
PURAPHARM: ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Futu NewsMar 28 10:06 ET · Announcements
No Data
No Data